L’Oreal invests in China’s Veminsyn for R&D
L’Oreal has taken a minority stake in Chinese biotech firm Veminsyn to co-develop sustainable bioactive ingredients for cosmetics. Backed by L'Oreal's BOLD fund and China’s Meicifang Investment, the partnership will harness Veminsyn’s molecular design and biomanufacturing capabilities to advance sustainable and open innovation.